Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
&NA; Substantial effort has been devoted toward understanding the psychopharmacological effects of tryptamine hallucinogens, which are thought to be mediated by activation of 5‐HT2A and 5‐HT1A receptors. Recently, several psychoactive tryptamines based on the N,N‐diallyltryptamine (DALT) scaffold have been encountered as recreational drugs. Despite the apparent widespread use of DALT derivatives in humans, little is known about their pharmacological properties. We compared the binding affinities of DALT and its 2‐phenyl‐, 4‐acetoxy‐, 4‐hydroxy‐, 5‐methoxy‐, 5‐methoxy‐2‐methyl‐, 5‐fluoro‐, 5‐fluoro‐2‐methyl‐, 5‐bromo‐, and 7‐ethyl‐derivatives at 45 receptor and transporter binding sites. Additionally, studies in C57BL/6 J mice examined whether these substances induce the head twitch response (HTR), a 5‐HT2A receptor‐mediated response that is widely used as a behavioral proxy for hallucinogen effects in humans. Most of the test drugs bound to serotonin receptors, &sgr; sites, &agr;2‐adrenoceptors, dopaminergic D3 receptors, histaminergic H1 receptors, and the serotonin transporter. DALT and several of the ring‐substituted derivatives were active in the HTR assay with the following rank order of potency: 4‐acetoxy‐DALT > 5‐fluoro‐DALT > 5‐methoxy‐DALT > 4‐hydroxy‐DALT > DALT > 5‐bromo‐DALT. 2‐Phenyl‐DALT, 5‐methoxy‐2‐methyl‐DALT, 5‐fluoro‐2‐methyl‐DALT, and 7‐ethyl‐DALT did not induce the HTR. HTR potency was not correlated with either 5‐HT1A or 5‐HT2A receptor binding affinity, but a multiple regression analysis indicated that 5‐HT2A and 5‐HT1A receptors make positive and negative contributions, respectively, to HTR potency (R2 = 0.8729). In addition to supporting the established role of 5‐HT2A receptors in the HTR, these findings are consistent with evidence that 5‐HT1A activation by tryptamine hallucinogens buffers their effects on HTR. This article is part of the Special Issue entitled ‘Psychedelics: New Doors, Altered Perceptions’. HighlightsA new class of recreational drugs are derived from N,N‐Diallyltryptamine (DALT).DALT derivatives are relatively nonselective for serotonin receptors.DALT derivatives induce the head twitch response (a 5‐HT2A‐mediated behavior) in mice.Both 5‐HT2A and 5‐HT1A receptors contribute to head twitch potency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
González-Maeso, J., Weisstaub, N. V., Zhou, M., Chan, P., Ivic, L., Ang, R., Lira, A., Bradley-Moore, M., Ge, Y., Zhou, Q., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.008 · Cited by 925 · cited 2×
“The HTR is widely used as a behavioral proxy in rodents for human hallucinogenic effects because it is one of only a few behaviors that can reliably distinguish hallucinogenic and non-hallucinogenic 5-HT2A receptor agonists (Gonzalez-Maeso et al. 2007).”
Amargos-Bosch, M. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhg128 · Cited by 370
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
Halberstadt, A. L. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.016 · Cited by 312 · cited 2×
“Over the past decade there has been a renewed focus on the pharmacology and effects of serotonergic hallucinogens (Halberstadt, 2015; Nichols, 2016).”
Self-citationHuman psychopharmacology of N,N-dimethyltryptamine
Strassman, R. J. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00081-2 · Cited by 261 · cited 1×
“Pretreatment with the mixed 5-HT 1A / β -adrenergic antagonist pindolol markedly augments the subjective response induced by the hallucinogen N,N -dimethyltryptamine (DMT) in human volunteers, suggesting that 5-HT 1A activation by DMT may blunt its 5-HT 2A -mediated effects (Strassman 1996).”
Halberstadt, A. L., Koedood, L., Powell, S. B., & Geyer, M. A. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110388326 · Cited by 213
Self-citationEffect of ring fluorination on the pharmacology of hallucinogenic tryptamines
Blair, J. B., Kurrasch-Orbaugh, D., Marona-Lewicka, D., Cumbay, M. G., Watts, V. J., Barker, E. L., & Nichols, D. E. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000339w · Cited by 131 · cited 1×
“This is consistent with reports demonstrating that 4-hydroxy-DMT (psilocin) binds to 5-HT1A sites with 20-fold lower affinity compared to its 5-hydroxy isomer (bufotenine) or the 5-hydroxy O-methyl derivative (5-methoxy-DMT), whereas there is little difference between their 5-HT2A receptor affinities (McKenna et al.,…”
Blough, B. E., Landavazo, A., Decker, A. M., Partilla, J. S., Baumann, M. H., & Rothman, R. B. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3557-7 · Cited by 101 · cited 1×
“In addition to producing effects via the 5-HT2A receptor, tryptamine hallucinogens also bind to 5-HT1A receptors with moderate to high affinity and efficacy (McKenna et al., 1990; Blough et al., 2014; Rickli et al., 2016).”
Cited by
Halberstadt, A. L., Chatha, M., Klein, A. K., Wallach, J., & Brandt, S. D. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107933 · Cited by 278
“To date, we have tested a variety of hallucinogens in the HTR paradigm (Halberstadt and Geyer, 2013, 2014; Brandt et al., 2017; Klein et al., 2018; Halberstadt et al., 2019a, 2019b).”
Self-citationDesigner drugs: mechanism of action and adverse effects
Luethi, D., & Liechti, M. E. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02693-7 · Cited by 262
Jensen, A. A., Halberstadt, A. L., Märcher-Rørsted, E., Odland, A. U., Chatha, M., Speth, N., Liebscher, G., Hansen, M., Bräuner-Osborne, H., Palner, M., et al. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113979 · Cited by 28
Self-citation
Metadata
- Authors
- Klein, L. M., Cozzi, N. V., Daley, P. F., Brandt, S. D., & Halberstadt, A. L.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2018-11
- Volume
- 142
- Pages
- 231-239
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2789608017
- Cited by
- 43
- References
- 8
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs. https://app.cochat.ai/papers/10.1016/j.neuropharm.2018.02.028
- The paper
- Klein, L. M., Cozzi, N. V., Daley, P. F., Brandt, S. D., & Halberstadt, A. L. (2018). Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2018.02.028
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.